Loading…
Anbio Biotechnology is projected to rise to $43.17 by 2027, a +32% move from its current price of $32.79. NNNN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $31.54 | $32.83 | $34.17 | +0.13% |
| May 30 | $31.06 | $32.87 | $34.79 | +0.26% |
| May 31 | $30.71 | $32.92 | $35.28 | +0.39% |
| Jun 1 | $30.42 | $32.96 | $35.71 | +0.52% |
| Jun 2 | $30.18 | $33.00 | $36.09 | +0.65% |
| Jun 3 | $29.96 | $33.04 | $36.45 | +0.78% |
| Jun 4 | $29.76 | $33.09 | $36.78 | +0.91% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.76 | $33.09 | $36.78 | +0.91% |
| Week 2 | $28.74 | $33.39 | $38.78 | +1.82% |
| Week 3 | $28.04 | $33.69 | $40.47 | +2.74% |
| Week 4 | $27.50 | $33.99 | $42.02 | +3.67% |
| Week 5 | $27.07 | $34.30 | $43.47 | +4.61% |
| Week 6 | $26.70 | $34.61 | $44.87 | +5.56% |
| Week 7 | $26.39 | $34.92 | $46.22 | +6.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Anbio Biotechnology operates in the healthcare sector, focusing on in vitro diagnostics (IVD). It serves markets in the European Union, the Asia Pacific, North America, South America, and internationally.
The company offers a range of IVD solutions including lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits.
It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Anbio Biotechnology (NNNN) is a healthcare stock with a current price of $32.52.
It has a market cap of $1.43B and is ranked 2270.
The near-term technical picture is bullish, with RSI14 at 70, SMA50 at $26.43 and SMA200 at $30.39. Key levels are support at $25.07 and resistance at $32.52, and the 30-day range runs from $24.58 to $43.03.
Forecast outlook shows a neutral stance in 2026 (avg $32.52, min $19.29, max $49.78, ROI 0) and a bullish trajectory thereafter. From 2027 onward, the averages rise through 2028 ($49.20), 2029 ($57.19), 2030 ($76.36), 2031 ($103.12), 2032 ($109.56), 2033 ($114.19), 2034 ($124.47), 2035 ($126.02), 2040 ($247.50), and 2050 ($635.77), with progressively larger ROIs (29, 51.3, 75.8, 134.8, 217.1, 236.9, 251.2, 282.8, 287.5, 661.1, 1855) and a bullish sentiment across the horizon.
A major floor 41.2% below — a decisive break under it would weaken the trend.
The nearest floor, 23.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.7% away) — a breakout level to watch.
A major ceiling 16.6% above — clearing it would confirm fresh momentum.
Key NNNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NNNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $32.08 | Buy | $31.94 | Buy |
| MA 10 | $29.81 | Buy | $30.60 | Buy |
| MA 20 | $28.58 | Buy | $29.24 | Buy |
| MA 50 | $26.90 | Buy | $27.69 | Buy |
| MA 100 | $26.82 | Buy | $27.42 | Buy |
| MA 200 | $30.23 | Buy | $26.70 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.53 | Neutral |
| Stoch RSI (14) | 86.09 | Sell |
| CCI (20) | 118.90 | Buy |
| Williams %R (14) | -2.77 | Info |
| MACD (12,26,9) | 0.61 | Buy |
| ROC (12) | 26.90 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 97.23 | Sell |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 3.90 | Buy |
| Ultimate (7,14,28) | 73.37 | Sell |
| Momentum (10) | 6.99 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 33.49 | Sell |
| ADX (14) | 20.54 | Buy |
| ATR (14) | 1.02 | Info |
The 30-day technical picture indicates a bullish tilt. RSI14 is 70, suggesting strong momentum.
The stock trades with a 50-day average of $26.43 and a 200-day average of $30.39. Support is identified at $25.07, while resistance sits at $32.52. The 30-day price range spans from $24.58 to $43.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.29 | $32.79 | $50.15 | 0% | Neutral | |
| $32.06 | $43.17 | $62.64 | +32% | Bullish | |
| $37.48 | $52.96 | $81.10 | +62% | Bullish | |
| $42.89 | $63.18 | $100.89 | +93% | Bullish | |
| $55.24 | $84.47 | $139.69 | +158% | Bullish | |
| $72.09 | $114.13 | $194.59 | +248% | Bullish | |
| $74.41 | $121.76 | $213.29 | +271% | Bullish | |
| $76.18 | $128.64 | $230.90 | +292% | Bullish | |
| $82.49 | $143.57 | $263.51 | +338% | Bullish | |
| $82.40 | $147.71 | $276.74 | +350% | Bullish | |
| $143.61 | $296.13 | $604.13 | +803% | Bullish | |
| $349.13 | $775.84 | $1,784.42 | +22.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.29 | $32.79 | $38.97 | +0.00% |
| June 2026 | $29.51 | $35.16 | $43.24 | +7.21% |
| July 2026 | $30.52 | $36.87 | $46.35 | +4.89% |
| August 2026 | $29.76 | $36.37 | $46.47 | -1.38% |
| September 2026 | $29.76 | $36.70 | $47.54 | +0.93% |
| October 2026 | $30.88 | $38.41 | $50.35 | +4.65% |
| November 2026 | $30.59 | $38.34 | $50.79 | -0.18% |
| December 2026 | $29.69 | $37.48 | $50.15 | -2.24% |
Click any year to see its month-by-month NNNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NNNN price prediction for 2026 points to an average of $32.79 (low $19.29, high $50.15) — a potential gain of 0% on today's $32.79. A consolidation phase looks the most probable path here.
In 2027, NNNN is projected to trade between $32.06 and $62.64, averaging $43.17 — a potential gain of +32% from today's $32.79. That is up +32% on the projected 2026 average. Momentum favours further upside here.
Anbio Biotechnology's 2028 outlook centres on $52.96, within a $37.48 to $81.10 range. That is up +23% on the projected 2027 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, NNNN could reach as high as $100.89, with a base case around $63.18 and support toward $42.89 — roughly +93% from $32.79. Momentum favours further upside here.
Expect NNNN to range from $55.24 to $139.69 through 2030. The $84.47 average target implies a +158% move from current prices. That is up +34% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The NNNN price prediction for 2031 points to an average of $114.13 (low $72.09, high $194.59) — a potential gain of +248% on today's $32.79. Momentum favours further upside here.
In 2032, NNNN is projected to trade between $74.41 and $213.29, averaging $121.76 — a potential gain of +271% from today's $32.79. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Anbio Biotechnology's 2033 outlook centres on $128.64, within a $76.18 to $230.90 range. That is up +6% on the projected 2032 average. That marks a +292% change versus current levels. Momentum favours further upside here.
By 2034, NNNN could reach as high as $263.51, with a base case around $143.57 and support toward $82.49 — roughly +338% from $32.79. Buyers look set to stay in control over this stretch.
Expect NNNN to range from $82.40 to $276.74 through 2035. The $147.71 average target implies a +350% move from current prices. That is up +3% on the projected 2034 average. Momentum favours further upside here.
The NNNN price prediction for 2040 points to an average of $296.13 (low $143.61, high $604.13) — a potential gain of +803% on today's $32.79. Buyers look set to stay in control over this stretch.
In 2050, NNNN is projected to trade between $349.13 and $1,784.42, averaging $775.84 — a potential gain of +22.7x from today's $32.79. That is up +162% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NNNN today (≈ 30.497103 NNNN) could be worth
$23,660.73
+$22,660.73 (+2266%) by 2050 · US Dollar
Based on the average projected NNNN price of $775.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NNNNwould be worth at today's price.
$1,000 invested in NNNN on May 27, 2025 (≈ 130.548305 NNNN) would be worth
$4,280.68
+$3,280.68 (+328.1%) today · 4.28× · US Dollar
Based on a NNNN entry price of $7.66 vs. today's $32.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $31.84 | $1,029.84 | +3.0% |
| 1 month ago | $27.65 | $1,185.9 | +18.6% |
| 3 months ago | $27.55 | $1,190.2 | +19.0% |
| 6 months ago | $23.43 | $1,399.49 | +39.9% |
| 1 year ago | $7.66 | $4,280.68 | +328.1% |
| All time (1.3y) ago | $5.77 | $5,682.84 | +468.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NNNN forecast.
Our base-case forecast reaches $66.00 around 2030.
Implied market cap at $66.00: $2.9B
The multi-year forecast shows a sustained uptrend with a bullish stance across the horizon. The 2030 average price is $76.36, with a max of $128.83 and a min of $48.82, and a ROI of 134.8.
Beyond 2030, the outlook remains bullish, with 2040 average $247.50 and ROI 661.1, and 2050 average $635.77 with ROI 1855. These figures imply substantial upside potential in the longer term, while continuing to reflect elevated volatility and uncertainty.
These projections are not guarantees. The asset's annualized volatility is 80%, which underscores the risk around future price paths and the possibility of meaningful downside alongside upside.
Tap a question to reveal the answer.
2030 avg $76.36, min $48.82, max $128.83, ROI 134.8, sentiment BULLISH.
The forecast shows a bullish trajectory from 2027 onward with rising averages (e.g., 2027 avg $41.95; 2028 avg $49.20; 2029 avg $57.19; 2030 avg $76.36) and increasing ROIs, though 2026 is Neutral with avg $32.52 and ROI 0. These are estimates, not guarantees.
Yes. In 2031 the max forecast is $179.58, while in 2030 the max is $128.83. The 2031 forecast therefore allows for a price above $100 in its upside scenario.
Current price is $32.52. Market cap is $1.43B. The rank is 2270.
RSI14 is 70. SMA50 is $26.43. SMA200 is $30.39. Support is $25.07 and resistance is $32.52. The 30-day range is $24.58 to $43.03, with a bullish sentiment.
Anbio Biotechnology Community Discussion
0Share your Anbio Biotechnology price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.